Letter to editor Sir, the recent report entitled "Correlation Between Obesity and High Density Lipoprotein Cholesterol (HDL-C) in Breast Cancer Patients of Southern Rajasth" is very interesting [1] . Inamdar et al. concluded that "only low HDL-C level had significant correlation with breast cancer and none of the other anthropometric measurements were associated with breast cancer [1] ." As Inamdar et al. noted, further systematic assessment is required. Indeed, low HDL-C level is reported for its association with increased postmenopausal breast cancer risk [2] . However, the main problem for final conclusion on such relationship is confounding factors. It should be noted that the metabolic syndrome, which is the larger superset of dyslipidemia, is also mentioned for its relationship to postmenopausal breast cancer risk [3, 4] . The more in depth genetic underlying which determine the lipid phenotype might be the solution for clarifying the clinical relationship.
